コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 pha-amylase in vitro, comparable to the drug acarbose.
2 f inhibition was assessed in comparison with acarbose.
3 far lower than that of the antidiabetic drug acarbose.
4 se, being almost 9 times more effective than acarbose.
5 with EC(50) values lower than that found for acarbose.
6 s effective as the pharmaceutical inhibitor, acarbose.
7 erium thermosaccharolyticum with and without acarbose.
8 s who do not respond to diet adjustments and acarbose.
9 lase, being nearly as potent an inhibitor as acarbose.
10 d glucose by the alpha-glucosidase inhibitor acarbose.
12 centralised computer system to receive oral acarbose (50 mg three times a day) or matched placebo, w
13 on (IC(50) = 4.48 +/- 0.32 muM), compared to acarbose (7.40 +/- 0.41 muM), based selectively on the p
15 diabetes medication other than metformin or acarbose alone, or 1 encounter with type 2 diabetes Inte
16 g bead immobilization and lectin analysis of acarbose, an antidiabetic drug, to dabsyl-tagged enzyme
20 xtracts potentiated the inhibition caused by acarbose and could replace the inhibition lost by reduci
21 ymethyl group of the nonreducing end of both acarbose and D-gluco-dihydroacarbose toward a more axial
22 report the complete biosynthetic pathway to acarbose and its structural components, GDP-valienol and
24 o model drugs of differing hydrophilicities, acarbose and ruxolitinib and 16 ILs, the dependence of s
25 and glucose transport were not inhibited by acarbose and that the presence of glucose induced lactul
26 he mechanisms underlying the synergy between acarbose and the berry polyphenols and the lack of syner
28 l diet containing 14 ppm rapamycin, 1000 ppm acarbose, and 1000 ppm phenylbutyrate was fed to 20-mont
29 protective advantage against the activity of acarbose, and are widespread in the microbiomes of weste
30 g behavior compared to the reference ligand, acarbose, as indicated by multiple structural parameters
31 ex soaked with the tetrasaccharide inhibitor acarbose, at 1.9 A, reveal a decasaccharide moiety, span
33 emonstrating that the glucoamylase inhibitor acarbose binds PhK, perturbs its structure, and stimulat
34 dy clarifies all previously unknown steps in acarbose biosynthesis and establishes a complete pathway
38 tallographic analysis of the enzyme in free, acarbose-complexed, and trapped 5-fluoro-beta-glucosyl-e
41 nits, clearly demonstrates synthesis of this acarbose-derived decasaccharide by a two-step transglyco
43 eart disease and impaired glucose tolerance, acarbose did not reduce the risk of major adverse cardio
45 ase, isomaltase and glucoamylase activity by acarbose, epigallocatechin gallate, epicatechin gallate
49 uctose-glucose (FruGlu) and fructose-glucose-acarbose (FruGluA) solutions than from fructose-mannitol
50 ose-mannitol (FruMann) and fructose-mannitol-acarbose (FruMannA) solutions, but there was no differen
51 Diabetes developed less frequently in the acarbose group (436 [13%] of 3272; 3.17 per 100 person-y
52 470 (14%; 3.33 per 100 person-years) of 3272 acarbose group participants and in 479 (15%; 3.41 per 10
53 se changes (215 [7%] of 3263 patients in the acarbose group vs 150 [5%] of 3241 in the placebo group
56 ima GTase and its complex with the inhibitor acarbose have been determined at 2.6A and 2.5A resolutio
57 tetrasaccharides D-gluco-dihydroacarbose and acarbose have been refined to R-factors of 0.147 and 0.1
59 ol and ethyl acetate fractions comparable to acarbose (IC(50) = 120.43 ug/mL) with IC(50) values of 1
63 surpassing the efficacy of the standard drug acarbose (IC50: 77.42 ug/mL).These multifunctional silve
67 justment is the agreed first treatment step; acarbose is effective for late dumping syndrome symptoms
68 -dihydroacarbose (K1 = 10(-8) M) relative to acarbose (K1 = 10(-12) M) may stem in part from the weak
69 ic analyses, we show that microbiome-derived acarbose kinases are specific for acarbose, provide thei
72 he effect of the alpha-glucosidase inhibitor acarbose on cardiovascular outcomes in patients with cor
73 ar more powerful than the anti-diabetic drug acarbose, OPVS-E exhibited a strong antiradical capacity
74 extracts exhibited the potential to replace acarbose (or reduce the dose required) in its current cl
76 me-derived acarbose kinases are specific for acarbose, provide their harbouring organism with a prote
78 e to a non-antibiotic drug, and suggest that acarbose resistance has disseminated in the human microb
81 ural products, such as the antidiabetic drug acarbose, the crop protectant validamycin, and the natur
83 lidamycin A biosynthesis, as well as that of acarbose, the valienamine and validamine moieties are ul
84 tion therapy of metformin, glipizide XL, and acarbose to lower A1C to 6.7% and 2-day repeated hypogly
86 uM for pancreatic alpha-amylase (compared to acarbose with IC(50) values of 1.2 +/- 0.1 muM and 0.5 +